COMP <GO>
AXGN vs CBLL // REVENUE GROWTH (YOY)
Axogen Inc. (NASDAQ) VS. CeriBell Inc. (NASDAQ) • 15-METRIC TALLY: AXGN 8
— CBLL 2
▲ REVENUE GROWTH (YOY) LEADER: CBLL
LAST: $49.63 (+0.77%) • MKT CAP: $2.96B
revenue-growth
20.20%
LAST: $27.82 (+2.20%) • MKT CAP: $1.07B
revenue-growth
36.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AXGN VS. CBLL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AXGN | CBLL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.30% | 87.90% | -13.60 | CBLL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.60% | -35.00% | +32.40 | AXGN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.10% | -3.89% | +3.79 | AXGN | /fcf-yield <GO> |
| Operating Margin | -3.50% | -60.00% | +56.50 | AXGN | /operating-margins <GO> |
| Net Profit Margin | -7.00% | -60.00% | +53.00 | AXGN | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 20.20% | 36.10% | -15.90 | CBLL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 18.64 | 14.75 | +3.89 | AXGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | AXGN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 74.3 | 54.0 | +20.26 | AXGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.96B | $1.07B | $1.90B | AXGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AXGN REV | CBLL REV | AXGN GROSS % | CBLL GROSS % | AXGN FCF | CBLL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $225.2M | $89.1M | 74.3% | 87.9% | -$2.9M | -$41.6M |
| FY 2024 | $187.3M | $65.4M | 75.8% | 86.7% | $1.4M | -$36.4M |
| FY 2023 | $159.0M | $45.2M | — | — | -$12.9M | -$29.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AXGN // BETA 1.10
CBLL // BETA —